Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology and Therapeutics
|
December 21, 2024
Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial
Andrew H Ko, Do-Youn Oh, Janet Lau, et al.
The Oncologist
|
June 9, 2017
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS
Christopher H Lieu, Manuel Hidalgo, Jordan D Berlin, et al.
Journal of Gastrointestinal Cancer
|
January 23, 2014
90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study
Nicholas Fidelman, Robert K Kerlan, Randall A Hawkins, et al.
Pancreas
|
March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab
Katherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Breast Cancer Research and Treatment
|
February 15, 2016
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies
Amy Jo Chien, Alyson Cockerill, Craig Fancourt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
Andrew H Ko, Alexander C Jordan, Evan Tooker, et al.
The Oncologist
|
September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
Andrew H Ko, Patrick B Murphy, James D Peyton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Edward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Annals of Surgical Oncology
|
June 15, 2024
Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer
Phoebe N Miller, Fernanda Romero-Hernandez, Lucia Calthorpe, et al.
Cancer Discovery
|
June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A Zill, Claire Greene, Dragan Sebisanovic, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology and Therapeutics
|
December 21, 2024
Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial
Andrew H Ko, Do-Youn Oh, Janet Lau, et al.
The Oncologist
|
June 9, 2017
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS
Christopher H Lieu, Manuel Hidalgo, Jordan D Berlin, et al.
Journal of Gastrointestinal Cancer
|
January 23, 2014
90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study
Nicholas Fidelman, Robert K Kerlan, Randall A Hawkins, et al.
Pancreas
|
March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab
Katherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Breast Cancer Research and Treatment
|
February 15, 2016
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies
Amy Jo Chien, Alyson Cockerill, Craig Fancourt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
Andrew H Ko, Alexander C Jordan, Evan Tooker, et al.
The Oncologist
|
September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
Andrew H Ko, Patrick B Murphy, James D Peyton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Edward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Annals of Surgical Oncology
|
June 15, 2024
Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer
Phoebe N Miller, Fernanda Romero-Hernandez, Lucia Calthorpe, et al.
Cancer Discovery
|
June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A Zill, Claire Greene, Dragan Sebisanovic, et al.
Page
of 10